Figure 1
TNM stage distribution in 68 patients. The American Joint Committee TNM stage was II in 14 (20.6%) patients, III in 32 (47.1%), and IVa in 22 (32.3%), respectively.
Figure 1 | Radiation Oncology
TNM stage distribution in 68 patients. The American Joint Committee TNM stage was II in 14 (20.6%) patients, III in 32 (47.1%), and IVa in 22 (32.3%), respectively.